Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI

Autor:	Silvio Danese, Colleen Marano, Laurent Peyrin-Biroulet, S. R. Targan, Ramesh P. Arasaradnam, David Rowbotham, G. Van Assche, Jewel Johanns, Hongyan Zhang, W J Sandborn, Philippe Szapary, Rupert W. Leong, Bruce E. Sands, Christopher D. O'Brien
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry Internal medicine Ustekinumab Phases of clinical research Medicine business medicine.disease Gastroenterology Ulcerative colitis medicine.drug
Zdroj:	Zeitschrift für Gastroenterologie.
ISSN:	1439-7803
DOI:	10.1055/s-0039-1691869
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::31e928de4ce62525e0573090da097e90 https://doi.org/10.1055/s-0039-1691869 Zobrazit plný text záznamu